National pharmacovigilance programs in Arab countries: A quantitative assessment study-Reference-Cited by-同舟云学术

National pharmacovigilance programs in Arab countries: A quantitative assessment study

Published:2020-03-17 Issue:9 Volume:29 Page:1001-1010
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Alshammari Thamir M.¹²^ORCID,Alenzi Khalidah A.³,Ata Sondus I.⁴

Affiliation:

1. Saudi Food and Drug Authority Riyadh Saudi Arabia

2. Medication Safety Research Chair King Saud University Riyadh Saudi Arabia

3. Regional Drug Information Center Ministry of Health Tabuk Saudi Arabia

4. Pharmacy Services Department King Saud University Medical City Riyadh Saudi Arabia

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.4991

Reference23 articles.

1. The importance of pharmacovigilance: safety monitoring of medicinal products. World Health Organization Collaborating Centre for International Drug Monitoring Geneva Switzerland; 2002.http://apps.who.int/medicinedocs/pdf/s4893e/s4893e.pdf?ua=1. Accessed December 2019.

2. Pharmacovigilance: pharmacists’ perspective on spontaneous adverse drug reaction reporting

3. Engaging stakeholders in pharmacoepidemiology research: Current state and recommendations

4. Drug safety: The concept, inception and its importance in patients’ health

5. Knowledge and attitude of health-care professionals in hospitals towards pharmacovigilance in Saudi Arabia

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Audits and inspections of pharmacovigilance systems in Russia;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-04-19

2. Implementation of a Pharmacovigilance System in a Resources-Limited Country in the Context of COVID-19: Lebanon’s Success Story;Therapeutic Innovation & Regulatory Science;2022-09-15

3. Pharmacovigilance regulatory actions by national pharmacovigilance centers in Arab countries following COVID-19 pandemic;Expert Opinion on Drug Safety;2022-08-18

4. A Systematic Review of Pharmacovigilance Systems in Developing Countries Using the WHO Pharmacovigilance Indicators;Therapeutic Innovation & Regulatory Science;2022-06-03

5. Neurologists’ Knowledge, Practice, and Attitudes towards Pharmacovigilance and Adverse Drug Reactions Reporting Process in Epileptic Patients—Comparative Analysis from Poland and Egypt;International Journal of Environmental Research and Public Health;2022-03-31